Gossamer Bio, Inc. Common Stock

GOSS XNAS • PHARMACEUTICAL PREPARATIONS

Historical Short Interest Share

Chase Ink Business Preferred®

Earn Up to 150K Bonus Points

Transfer points to 14+ airline & hotel partners. Up to 40% upgrade value on first class travel. $95/yr.

Apply Now

Market Cap

66M

Short interest (Jul 15)

15.0%

Net Short (Jul 27 ): 3.7%

Borrow Fee

8.49%

↑ 17.3%

Available Shares

↓ 9.2%

Price Chart

Company Overview

Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension).

Company Info

Exchange: NASDAQ

Industry: PHARMACEUTICAL PREPARATIONS

CIK: 0001728117

Asset Type: CS

Market Data

Market Cap: $66,483,154

Employees: 162

Status: Active

Short Interest

Current Borrow Fee 8.49%

Range: 8.49% - 8.49%

Available Shares 4M

Range: 4.4M - 7.4M

Recent Changes

Fee Change: ↑ 47.1%

Available Change: ↓ 23.0%

Quick Actions

View Dilution Chart

Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam • Unsubscribe anytime